DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundation

Behavioural symptoms and capacity in dementia

Essential points for quick revision.

!
Escalate

Sudden agitation, drowsiness, hallucinations or refusal of care needs urgent assessment for delirium, pain, infection, retention, constipation, medicine toxicity, hypoxia and metabolic illness. Immediate serious harm may require proportionate emergency action, but dementia alone never authorises restraint, covert medication or treatment without a capacity and legal framework.

Synopsis

Formulate distress and behaviour in dementia through unmet need and delirium assessment, use antipsychotics only within strict risk criteria, and apply decision-specific Mental Capacity Act practice.

  • Describe the behaviour precisely—who, when, where, trigger, duration and consequence—rather than using 'challenging behaviour' as a diagnosis.
  • Before treatment perform a structured assessment for pain, delirium, infection, hunger, thirst, constipation, urinary retention, sleep, sensory loss, environment and communication.
  • Offer psychosocial and environmental interventions first when there is no emergency, matching meaningful activity, routine, lighting, noise and carer approach to the person.

Key red flags

Delirium superimposed on dementia

Acute fluctuating attention, altered arousal, sleep-wake reversal or new perceptual symptoms over hours to days indicates urgent delirium assessment even with established dementia.

Investigation priorities

01
Structured physical and delirium assessmentFirst step

Find acute illness, pain and physiological causes behind new behavioural change.

Management branches

Behaviour changeFind the need before choosing a drug

Distress, agitation, wandering, resistance or perceptual symptoms emerge or worsen.

  1. Define onset and behaviour precisely, assess immediate harm and perform urgent delirium, pain, retention, constipation, infection and medicine review.
  2. Ask what happens immediately before and after episodes, including staff language, personal-care task, noise, lighting, hunger and sensory access.

Key medicines

RisperidoneIf strictly indicated, use a low geriatric starting dose and titrate cautiously; the licensed persistent-aggression course in Alzheimer disease is limited to 6 weeks.
HaloperidolUse only the lowest effective short-term dose within its narrow licence and local specialist protocol after ECG and interaction risks are considered.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom